Company Profile
Lifevantage Stock Price, News & Catalysts
- Ticker:
- LFVN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
6.51 USD (-2.25%)
Close
Last updated: August 12, 2026
109M USD
Market cap
Why the stock is moving
The latest monitored company update is “LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026.” The corresponding closing-price reaction is not yet available.
Company overview
Direct-Selling Wellness Company
LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants.
Nutrigenomics Positioning
The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather than conventional nutrient replacement alone.
Product Portfolio
Key offerings include the Protandim line, the MindBody GLP-1 System and products added through LoveBiome. Sales depend on consultant recruitment, customer retention and product launches across international markets.
Future catalysts
- LifeVantage’s catalysts are product sales, distributor activity, and margin discipline in consumer wellness. The company improves when its recurring consumer base stays healthy.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Lifevantage (LFVN)?
Lifevantage (LFVN) most recently closed at 6.51 USD, a -2.25% move versus the previous session.
What is the market cap of Lifevantage (LFVN)?
Lifevantage currently has a market capitalization of 109M USD on BioPharmSignal.
What does Lifevantage do?
Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants. Nutrigenomics Positioning The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather than conventional...
On which exchange is LFVN stock listed?
Lifevantage (LFVN) is associated with NASDAQ, United States, Biopharma.
What is GLP-1?
Product Portfolio Key offerings include the Protandim line, the MindBody GLP-1 System and products added through LoveBiome.
Which conditions is Lifevantage targeting with GLP-1?
Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants. Nutrigenomics Positioning The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather than conventional...
How does Lifevantage describe recent progress with GLP-1?
LifeVantage’s catalysts are product sales, distributor activity, and margin discipline in consumer wellness. The company improves when its recurring consumer base stays healthy.
What is Direct-Selling?
Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants.